Journal of Virus Eradication最新文献

筛选
英文 中文
8.1 – 00022 Short-term Combination Immunotherapy with bNAbs and CCR5 Blockade Mediates ART-Free Viral Control in Infant Rhesus Macaques bnab和CCR5阻断短期联合免疫治疗介导婴儿恒河猴无art病毒控制
IF 3.5 4区 医学
Journal of Virus Eradication Pub Date : 2024-12-01 DOI: 10.1016/j.jve.2024.100436
N.L. Haigwood, T. Ordonez, S. Pandey, J. Reed, G.M. Webb, A.J. Hessell, K.K.A. Van Rompay, J.K. Watanabe, J.L. Usachenko, J. Sacha
{"title":"8.1 – 00022 Short-term Combination Immunotherapy with bNAbs and CCR5 Blockade Mediates ART-Free Viral Control in Infant Rhesus Macaques","authors":"N.L. Haigwood, T. Ordonez, S. Pandey, J. Reed, G.M. Webb, A.J. Hessell, K.K.A. Van Rompay, J.K. Watanabe, J.L. Usachenko, J. Sacha","doi":"10.1016/j.jve.2024.100436","DOIUrl":"10.1016/j.jve.2024.100436","url":null,"abstract":"","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"10 ","pages":"Pages 28-29"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143130231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
1.3 – 00084 Persistence of HIV genomes in bacteria-specific CD4+ T cells during ART 抗逆转录病毒治疗期间细菌特异性CD4+ T细胞中HIV基因组的持久性
IF 3.5 4区 医学
Journal of Virus Eradication Pub Date : 2024-12-01 DOI: 10.1016/j.jve.2024.100396
A. Espinosa Ortiz, R. Fromentin, S.G. Deeks, J.P. Routy, N. Chomont
{"title":"1.3 – 00084 Persistence of HIV genomes in bacteria-specific CD4+ T cells during ART","authors":"A. Espinosa Ortiz, R. Fromentin, S.G. Deeks, J.P. Routy, N. Chomont","doi":"10.1016/j.jve.2024.100396","DOIUrl":"10.1016/j.jve.2024.100396","url":null,"abstract":"","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"10 ","pages":"Page 2"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143176159","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2.2 – 00058 Role of HIV integration site on clonal expansion of infected cells and maintenance of latency in vivo 2.2 - 00058 HIV整合位点在感染细胞克隆扩增和维持体内潜伏期中的作用
IF 3.5 4区 医学
Journal of Virus Eradication Pub Date : 2024-12-01 DOI: 10.1016/j.jve.2024.100401
V. Pal, M. Frauke, A. Danesh, M. Canis, T. Dilling, I. Miller, T. Huynh, T. Hatziioannou, R.B. Jones, G.Q. Lee, P.D. Bieniasz
{"title":"2.2 – 00058 Role of HIV integration site on clonal expansion of infected cells and maintenance of latency in vivo","authors":"V. Pal, M. Frauke, A. Danesh, M. Canis, T. Dilling, I. Miller, T. Huynh, T. Hatziioannou, R.B. Jones, G.Q. Lee, P.D. Bieniasz","doi":"10.1016/j.jve.2024.100401","DOIUrl":"10.1016/j.jve.2024.100401","url":null,"abstract":"","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"10 ","pages":"Page 5"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143128930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PP3.5 – 00089 Investigating novel designed and synthesized PKC modulators for use in “kick and kill” HIV cure strategies 研究新设计和合成的PKC调节剂用于“踢死”HIV治疗策略
IF 3.5 4区 医学
Journal of Virus Eradication Pub Date : 2024-12-01 DOI: 10.1016/j.jve.2024.100486
J. Morán, Z. Gentry, O. Mcateer, J. Hamad, J.T. Kim, P. Wender, J. Zack, M. Marsden
{"title":"PP3.5 – 00089 Investigating novel designed and synthesized PKC modulators for use in “kick and kill” HIV cure strategies","authors":"J. Morán, Z. Gentry, O. Mcateer, J. Hamad, J.T. Kim, P. Wender, J. Zack, M. Marsden","doi":"10.1016/j.jve.2024.100486","DOIUrl":"10.1016/j.jve.2024.100486","url":null,"abstract":"","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"10 ","pages":"Pages 62-63"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143135196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PP3.7 – 00002 Towards a functional cure for HIV-1 infection: BRD4 modulator ZL0580 and LEDGINs additively block and lock HIV-1 transcription 迈向功能性治愈HIV-1感染:BRD4调节剂ZL0580和LEDGINs加性阻断和锁定HIV-1转录
IF 3.5 4区 医学
Journal of Virus Eradication Pub Date : 2024-12-01 DOI: 10.1016/j.jve.2024.100488
E. Pellaers, A. Denis, W. Hannes, A. Bhat, Z. Debyser
{"title":"PP3.7 – 00002 Towards a functional cure for HIV-1 infection: BRD4 modulator ZL0580 and LEDGINs additively block and lock HIV-1 transcription","authors":"E. Pellaers, A. Denis, W. Hannes, A. Bhat, Z. Debyser","doi":"10.1016/j.jve.2024.100488","DOIUrl":"10.1016/j.jve.2024.100488","url":null,"abstract":"","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"10 ","pages":"Pages 63-64"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143135198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PP4.6 – 00115 Disruption of intestinal germinal centers during HIV infection PP4.6 - 00115 艾滋病毒感染期间肠道生殖中心的破坏
IF 3.5 4区 医学
Journal of Virus Eradication Pub Date : 2024-12-01 DOI: 10.1016/j.jve.2024.100493
F. Cossarini, A. Krek, P. Canales-Herrerias, M. Tankelevich, B. Chen, J. Aberg, F. Petralia, A. Polydorides, S. Mehandru
{"title":"PP4.6 – 00115 Disruption of intestinal germinal centers during HIV infection","authors":"F. Cossarini, A. Krek, P. Canales-Herrerias, M. Tankelevich, B. Chen, J. Aberg, F. Petralia, A. Polydorides, S. Mehandru","doi":"10.1016/j.jve.2024.100493","DOIUrl":"10.1016/j.jve.2024.100493","url":null,"abstract":"","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"10 ","pages":"Page 67"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143180200","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
7.4 – 00119 Anatomic distribution of HIV-infected clones in tissues after longterm antiretroviral therapy 7.4 - 00119 经过长期抗逆转录病毒治疗后组织中受艾滋病毒感染的克隆的解剖分布情况
IF 3.5 4区 医学
Journal of Virus Eradication Pub Date : 2024-12-01 DOI: 10.1016/j.jve.2024.100433
F. Maldarelli, A. Glassey, T. Nguyen, R. Gorelick, L. Adams, M. Zipparo, A. Rahman, S. Hewitt, K. Lurain, R. Ramiswami, C.Y. Lau
{"title":"7.4 – 00119 Anatomic distribution of HIV-infected clones in tissues after longterm antiretroviral therapy","authors":"F. Maldarelli, A. Glassey, T. Nguyen, R. Gorelick, L. Adams, M. Zipparo, A. Rahman, S. Hewitt, K. Lurain, R. Ramiswami, C.Y. Lau","doi":"10.1016/j.jve.2024.100433","DOIUrl":"10.1016/j.jve.2024.100433","url":null,"abstract":"","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"10 ","pages":"Page 27"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143181179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PP3.6 – 00064 Novel synthesized protein kinase C modulators show enhanced HIV latency reversal properties and synergize with a BET bromodomain inhibitor 新合成的蛋白激酶C调节剂具有增强的HIV潜伏期逆转特性,并与BET溴域抑制剂协同作用
IF 3.5 4区 医学
Journal of Virus Eradication Pub Date : 2024-12-01 DOI: 10.1016/j.jve.2024.100487
T.C. Chou, J.A. Moran, J. Zack, P. Wender, M.D. Marsden
{"title":"PP3.6 – 00064 Novel synthesized protein kinase C modulators show enhanced HIV latency reversal properties and synergize with a BET bromodomain inhibitor","authors":"T.C. Chou, J.A. Moran, J. Zack, P. Wender, M.D. Marsden","doi":"10.1016/j.jve.2024.100487","DOIUrl":"10.1016/j.jve.2024.100487","url":null,"abstract":"","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"10 ","pages":"Page 63"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143135197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Virological and serological outcomes in people with HIV-HBV coinfection who had discontinued tenofovir-containing antiretroviral therapy: Results from a prospective cohort study 停止含替诺福韦抗逆转录病毒治疗的HIV-HBV合并感染患者的病毒学和血清学结果:一项前瞻性队列研究的结果
IF 3.5 4区 医学
Journal of Virus Eradication Pub Date : 2024-12-01 DOI: 10.1016/j.jve.2024.100574
Amir M. Mohareb , Patrick Miailhes , Julie Bottero , Caroline Lascoux-Combe , Julie Chas , Sarah Maylin , Audrey Gabassi , Hayette Rougier , Emily P. Hyle , Constance Delaugerre , Karine Lacombe , Anders Boyd
{"title":"Virological and serological outcomes in people with HIV-HBV coinfection who had discontinued tenofovir-containing antiretroviral therapy: Results from a prospective cohort study","authors":"Amir M. Mohareb ,&nbsp;Patrick Miailhes ,&nbsp;Julie Bottero ,&nbsp;Caroline Lascoux-Combe ,&nbsp;Julie Chas ,&nbsp;Sarah Maylin ,&nbsp;Audrey Gabassi ,&nbsp;Hayette Rougier ,&nbsp;Emily P. Hyle ,&nbsp;Constance Delaugerre ,&nbsp;Karine Lacombe ,&nbsp;Anders Boyd","doi":"10.1016/j.jve.2024.100574","DOIUrl":"10.1016/j.jve.2024.100574","url":null,"abstract":"<div><h3>Background and Aims</h3><div>Given advances in antiretroviral therapy (ART), some people with HIV are transitioned to non-tenofovir-containing ART; the implications for people with HIV-hepatitis B virus (HBV) are unknown. We characterized HBV-related outcomes in people with HIV-HBV coinfection while not taking tenofovir-containing ART.</div></div><div><h3>Methods</h3><div>We analyzed participants from the French HIV-HBV Cohort Study in three treatment groups: (1) continuous tenofovir; (2) discontinued tenofovir; (3) never initiated tenofovir. We examined virological and clinical characteristics during follow-up. We assessed determinants of HBV DNA &gt;2000 IU/mL and alanine aminotransferase (ALT) &gt;2x upper limit of normal separately while participants were off tenofovir using univariable logistic regression with generalized estimating equations.</div></div><div><h3>Results</h3><div>Among 192 participants, 161 (83.9 %) were on continuous tenofovir, 22 (11.5 %) discontinued tenofovir, and 9 (4.7 %) never initiated tenofovir during a median follow-up of 14.5 years (IQR = 10.5–14.8). The median proportion of within-participant visits with undetectable HBV DNA was 96.0 % (IQR = 75.0–100) in the continuous group, 100 % (IQR = 84.0–100) in the discontinued tenofovir group (while off tenofovir), and 100 % (IQR = 95.2–100) in the never initiated tenofovir group. Determinants of HBV DNA &gt;2000 IU/mL while people were off tenofovir were detectable HIV RNA (<em>p</em> = 0.041), lower CD4<sup>+</sup> T-cell count (<em>p</em> = 0.027), HBeAg positive serology (<em>p</em> = 0.004) and positive hepatitis D serology (<em>p</em> = 0.001). ALT elevation was associated with positive hepatitis C antibody serology (<em>p</em> = 0.012).</div></div><div><h3>Conclusions</h3><div>This proof-of-concept study shows that selected people with HIV-HBV coinfection may not lose virologic control of HBV when off tenofovir. HBV virologic activity while off tenofovir may be more closely associated with uncontrolled HIV infection and positive HBeAg serology.</div></div>","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"10 4","pages":"Article 100574"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143105156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
6.2 – 00049 Multivalent CAR T Cell Therapy Shows Superior Potency in Controlling HIV Escape and Replication in BLT Humanized Mice 多价CAR - T细胞疗法在控制BLT人源化小鼠的HIV逃逸和复制方面显示出优越的效力
IF 3.5 4区 医学
Journal of Virus Eradication Pub Date : 2024-12-01 DOI: 10.1016/j.jve.2024.100425
F. Severi, D. Bercow, K. Stallings, A. Criswell, F. Pennino, R. Acosta, T. Yang, D. Claiborne
{"title":"6.2 – 00049 Multivalent CAR T Cell Therapy Shows Superior Potency in Controlling HIV Escape and Replication in BLT Humanized Mice","authors":"F. Severi,&nbsp;D. Bercow,&nbsp;K. Stallings,&nbsp;A. Criswell,&nbsp;F. Pennino,&nbsp;R. Acosta,&nbsp;T. Yang,&nbsp;D. Claiborne","doi":"10.1016/j.jve.2024.100425","DOIUrl":"10.1016/j.jve.2024.100425","url":null,"abstract":"","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"10 ","pages":"Page 21"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143128836","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信